UPLOAD Filing
Processa Pharmaceuticals, Inc.
Date: Aug. 13, 2025 · CIK: 0001533743 · Accession: 0000000000-25-008493
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-39531
Letter
Re: Processa Pharmaceuticals, Inc. Preliminary Proxy Statement on Schedule 14A Filed July 31, 2025 File No. 001-39531 Dear Russell Skibsted:
August 13, 2025
Russell Skibsted Chief Financial Officer Processa Pharmaceuticals, Inc. 601 21st Street, Suite 300 Vero Beach, FL, 32960
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
cc: Michael Kirwan
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 13, 2025 Russell Skibsted Chief Financial Officer Processa Pharmaceuticals, Inc. 601 21st Street, Suite 300 Vero Beach, FL, 32960 Re: Processa Pharmaceuticals, Inc. Preliminary Proxy Statement on Schedule 14A Filed July 31, 2025 File No. 001-39531 Dear Russell Skibsted: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael Kirwan </TEXT> </DOCUMENT>